Status:
RECRUITING
CARDSUP - SWISS Circulatory Support Registry
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The project's main goal is to collect baseline clinical and procedural data as well as to assess clinical outcomes for all patients undergoing ECMO or Impella implantation at all included sites. All p...
Detailed Description
This prospective data collection is made up of an all-comers design, including all eligible consecutive patients receiving an Impella (2.5, 5, CP, or RP) or VA-ECMO device via femoral access who gave ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Medical indication for implantation of a peripheral cannulated VA-ECMO or microaxial flow pump (IMPELLA) or newer LV / LA-Ascending Aorta devices.
- Signed informed consent by patient or relative or waived consent by EC
Exclusion
- None
Key Trial Info
Start Date :
August 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2034
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04117230
Start Date
August 9 2019
End Date
August 31 2034
Last Update
December 6 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitätsspital Basel
Basel, Switzerland, 4053
2
Insel Gruppe AG, Inselspital Bern
Bern, Switzerland, 3010
3
Luzerner Kantonsspital
Lucerne, Switzerland, 3600
4
Kantonsspital Winterthur
Winterthur, Switzerland, 8400